Concepedia

Bouke Koeneman

BK

Statistics

Publications

4

Citations

86

H-Index

4

Active since

2019

Affiliations

Radboud University Medical Center(Current)

Radboud University Nijmegen

Radboud Institute for Molecular Life Sciences

Bouke Koeneman is an author at Radboud University Medical Center specializing in oncology, immunology, and tumor antigen-based immunotherapy.

ORCID

Publications per year

2019–2024

4

Publications

4

Adjuvant dendritic cell therapy in stage IIIB/C melanoma: the MIND-DC randomized phase III trial

Kalijn F. Bol, Gerty Schreibelt, Martine Bloemendal et al. · Nature Communications · 2024 · 42 citations · Full text

, , +17

Dendritic cell vaccination combined with carboplatin/paclitaxel for metastatic endometrial cancer patients: results of a phase I/II trial

Bouke Koeneman, Gerty Schreibelt, Mark A.J. Gorris et al. · Frontiers in Immunology · 2024 · 22 citations · Full text

, , +17

A randomized double‐blind, placebo‐controlled clinical phase IIa trial on safety, immunomodulatory effects and pharmacokinetics of EA‐230 during experimental human endotoxaemia

Roger van Groenendael, Matthijs Kox, Guus P. Leijte et al. · British Journal of Clinical Pharmacology · 2019 · 12 citations · Full text

, , +14

Design of TOLERANT: phase I/II safety assessment of intranodal administration of HSP70/mB29a self-peptide antigen-loaded autologous tolerogenic dendritic cells in patients with rheumatoid arthritis

Arie Jan Stoppelenburg, Gerty Schreibelt, Bouke Koeneman et al. · BMJ Open · 2024 · 10 citations · Full text

, , +17

1–4 of 4